Alita Pharmaceuticals, Inc. is a specialty pharmaceutical company founded by Warburg Pincus together with the company’s Chief Executive Officer, Carole Ben-Maimon, M.D., in September 2006 to focus on licensing, developing, and commercializing novel treatments for diseases in urology and women’s health. At founding, Warburg Pincus provided the company with a $30 million equity line of credit. Since its founding, Alita has successfully licensed its first product, targeted at preventing recurrent urinary tract infections, and is actively pursuing additional licensing opportunities.
Back
to Previous Page